ALNY

NASD Alnylam Pharmaceuticals, Inc
Oct 16, 2026 · 8:34 AM ET LAST TRADE Market Closed

$232.51 ↓ -1.52 (-0.65%) Trading Down from the previous close of $234.03

YTD change
-41.53%
vs 20-day SMA
-1.68%
vs 200-day SMA
-21.22%

Price ranges

Previous day
$228.12 $234.30
open $230.00 close $234.03
+$4.03 (+1.75%)
Today
$0.00 $0.00
$232.51
Past week
$221.56 $234.30
from $224.53 now $232.51
+$7.98 (+3.55%)
Past month
$215.46 $257.27
from $245.51 now $232.51
-$13.00 (-5.30%)
This year
$197.81 $427.05
from $397.65 now $232.51
-$165.14 (-41.53%)

Price & Performance

-86.10 (-26.90%) / 6M

$196.04$241.67$287.31$332.94Apr 16Jul 17Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 53.1% away from all-time highs of $495.55
  • ALNY is down 42% since the beginning of the year
  • ALNY is down 52% over the past 12 months
  • ALNY is down 5% over the past 1 month
  • 6% of all ALNY investors are betting against ALNY

ALNY reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -51.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $1.21
Earnings momentum +30.5% Quarterly EPS growth
Quarterly change +30.5%

Valuation

P/E ratio 37.79
Enterprise value $32.0B
Beta 0.95

Balance sheet & scale

Income$808.0K
Revenue$4.8B
Cash$3.3B
Debt$3.0M
Income / Debt 0.27×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $31.1B

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,251.61 +3.55%
JNJ Johnson & Johnson $253.28 -0.25%
ABBV AbbVie, Inc. $283.40 -0.03%
MRK Merck & Co., Inc. $145.19 -1.48%
RHHVF Roche Holding Ltd $457.03 +1.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.